Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Skin Cancer Prevention 1Lung Neoplasms 1

Interventions

Cyclophosphamide 908Carboplatin 785Paclitaxel 739pembrolizumab 738Cisplatin 707Bevacizumab 705Gemcitabine 619Docetaxel 578Rituximab 548Radiotherapy 539Dexamethasone 510Nivolumab 485Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 357Pemetrexed 334Cytarabine 334Oxaliplatin 333Lenalidomide 327Prednisone 326fludarabine phosphate 315Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Motivational Interviewing × Clear all
NCT00580398 2018-10-12

Smoking Cessation Intervention for Thoracic Patients

Massachusetts General Hospital

Phase 1/2 Completed
49 enrolled 10 charts
Thoracic

Lung Neoplasms

NCT00709306 2018-08-31

The Skin Savvy Study: A Behavioral Skin Cancer Prevention Intervention

Fox Chase Cancer Center

Phase NA Completed
197 enrolled 11 charts
Dermatologic

Skin Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡